Efficacy and Safety of ME3183 in Subjects With Moderate to Severe Plaque Psoriasis
Clinical trial NCT05268016 · COMPLETED
Trial details
- NCT number
- NCT05268016
- Sponsor
- Meiji Pharma USA Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-24
- Primary completion
- 2023-05-31
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.